Accolate zafirlukast regulatory update

FDA said it is reviewing postmarketing reports of behavior and mood changes, suicidality and suicide in Accolate zafirlukast from AstraZeneca and Zyflo zileuton and Zyflo CR from Critical Therapeutics...